Answers are grounded in this paper and cite their sources.
Liver fibrosis represents a progressive pathological process characterized by the excessive accumulation of extracellular matrix (ECM), ultimately disrupting hepatic architecture and function. MicroRNAs (miRNAs) have emerged as critical post-transcriptional regulators in fibrogenesis, functioning both independently and through exosome-mediated intercellular communication pathways. This review synthesizes recent advancements regarding the regulatory roles of intracellular and exosome-mediated miRNA signaling in liver fibrogenesis. We examine how specific intracellular miRNAs modulate critical fibrotic pathways, including oxidative stress, inflammatory signaling, hepatic stellate cell (HSC) activation, and lipid metabolism. We further discuss intercellular communication mediated by exosomal miRNAs derived from hepatocytes, HSCs, macrophages, and mesenchymal stem cells (MSCs) and other cell types. Finally, we evaluate the translational potential of miRNA-based biomarkers and exosome-based therapeutics, with emphasis on technical limitations, targeting efficiency, safety, and other barriers to clinical application. This review aims to provide a clearer understanding of miRNA–exosome networks that may facilitate the development of novel diagnostic and therapeutic approaches for liver fibrosis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: